• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在严重增殖性糖尿病视网膜病变中,使用高速23G经结膜无缝合玻璃体切除术分割并切除纤维血管膜。

Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy.

作者信息

Celik Erkan, Sever Ozkan, Horozoglu Fatih, Yanyalı Ates

机构信息

Sakarya University Medical Education and Research Hospital, Sakarya, Turkey.

Namik Kemal University, School of Medicine, Tekirdag, Turkey.

出版信息

Clin Ophthalmol. 2016 May 17;10:903-10. doi: 10.2147/OPTH.S95145. eCollection 2016.

DOI:10.2147/OPTH.S95145
PMID:27274192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4876088/
Abstract

AIM

To evaluate the effectiveness and safety of high-speed (5,000 cuts per minute) 23 G transconjunctival sutureless vitrectomy (TSV) in severe diabetic fibrovascular proliferation (DFVP).

PATIENTS AND METHODS

In this retrospective consecutive case series, patients who underwent 23 G TSV for severe DFVP between October 2011 and March 2014 at our institution were evaluated. 23 G TSV was performed with a high-speed (5,000 cuts per minute) cutter without a chandelier light.

RESULTS

The mean follow-up period was 8 months (range: 4-23 months). Of the 27 eyes of 27 patients, 14 eyes (52%) underwent concomitant phacoemulsification with posterior chamber intraocular lens implantation, nine eyes (33%) were pseudophakic, and four eyes were phakic (15%). DFVP was removed with ease in all, and visual acuity was improved in 18 (67%) eyes. Iatrogenic retinal tear was observed in four eyes (15%) and treated successfully during surgery. Suture placement to a single sclerotomy was performed in eight eyes (30%). Postoperative intraocular hemorrhage was observed in five eyes (18%). Cataract formation was observed in two of the four phakic eyes. Three (11%) patients had postoperative intraocular pressure rise. Postoperative hypotony (≤6 mmHg) and endophthalmitis were not observed in any eye.

CONCLUSION

The segmentation and removal of fibrovascular membranes with high-speed 23 G TSV seems to be a safe and easy method in severe diabetic eye disease.

摘要

目的

评估高速(每分钟5000次切割)23G经结膜无缝合玻璃体切除术(TSV)治疗重度糖尿病性纤维血管增殖(DFVP)的有效性和安全性。

患者与方法

在本回顾性连续病例系列研究中,对2011年10月至2014年3月期间在我院接受23G TSV治疗重度DFVP的患者进行评估。23G TSV使用高速(每分钟5000次切割)切割器且无吊灯照明进行。

结果

平均随访期为8个月(范围:4 - 23个月)。27例患者的27只眼中,14只眼(52%)同时行超声乳化白内障吸除联合后房型人工晶状体植入术,9只眼(33%)为人工晶状体眼,4只眼(15%)为晶状体眼。所有患者的DFVP均轻松切除,18只眼(67%)视力得到改善。4只眼(15%)观察到医源性视网膜裂孔并在手术中成功处理。8只眼(30%)对单个巩膜切口进行了缝线固定。5只眼(18%)观察到术后眼内出血。4只晶状体眼中有2只眼观察到白内障形成。3例(11%)患者术后眼压升高。未观察到任何一只眼出现术后低眼压(≤6 mmHg)和眼内炎。

结论

高速23G TSV分割和切除纤维血管膜在重度糖尿病眼病中似乎是一种安全、简便的方法。

相似文献

1
Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy.在严重增殖性糖尿病视网膜病变中,使用高速23G经结膜无缝合玻璃体切除术分割并切除纤维血管膜。
Clin Ophthalmol. 2016 May 17;10:903-10. doi: 10.2147/OPTH.S95145. eCollection 2016.
2
25-Gauge transconjunctival sutureless pars plana vitrectomy.25G 经结膜无缝合玻璃体切除术
Eur J Ophthalmol. 2006 Jan-Feb;16(1):141-7. doi: 10.1177/112067210601600123.
3
Combined 23-gauge transconjunctival sutureless vitrectomy and cataract surgery in cases with cataract and posterior segment diseases.23G 经结膜无缝线玻璃体切除术联合白内障手术治疗合并白内障及后段疾病的病例
Middle East Afr J Ophthalmol. 2010 Oct;17(4):359-64. doi: 10.4103/0974-9233.71602.
4
Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.合并 23G 无缝线玻璃体切除术和透明角膜超声乳化术治疗增生性糖尿病视网膜病变。
Retina. 2011 Oct;31(9):1753-8. doi: 10.1097/IAE.0b013e31820d4057.
5
Early postoperative intraocular pressure stability after combined 23-gauge sutureless vitrectomy and cataract surgery in patients with proliferative diabetic retinopathy.增生型糖尿病视网膜病变患者行 23G 免缝线玻璃体切割联合白内障手术后的早期术后眼内压稳定性。
Retina. 2012 Oct;32(9):1767-74. doi: 10.1097/IAE.0b013e3182475ad6.
6
23-Gauge transconjunctival sutureless vitrectomy for retained lens fragments after complicated cataract surgery.23 号经结膜无缝线玻璃体切除术治疗复杂白内障手术后残留的晶状体碎片。
Retina. 2012 Mar;32(3):493-8. doi: 10.1097/IAE.0b013e3182252b13.
7
[Outcomes of 27G(+) transconjunctival sutureless vitrectomy for posterior segment disease].27G(+)经结膜无缝合玻璃体切除术治疗眼后段疾病的疗效
Zhonghua Yan Ke Za Zhi. 2018 Dec 11;54(12):918-922. doi: 10.3760/cma.j.issn.0412-4081.2018.12.009.
8
Influence of silicone oil tamponade on self-sealing sclerotomy using 25-gauge transconjunctival sutureless vitrectomy: a retrospective comparative study.硅油填充对25G经结膜无缝合玻璃体切割术巩膜穿刺口自闭的影响:一项回顾性对照研究
BMC Ophthalmol. 2015 Dec 1;15:171. doi: 10.1186/s12886-015-0159-z.
9
Outcomes after combined 1.8-MM microincision cataract surgery and 23-gauge transconjunctival vitrectomy for posterior segment disease: a retrospective study.1.8 毫米微切口白内障手术联合 23 号经结膜玻璃体切割术治疗后节疾病的疗效:一项回顾性研究。
Retina. 2014 Jan;34(1):142-8. doi: 10.1097/IAE.0b013e3182947b29.
10
[Transconjunctival vitrectomy: preliminary data using the TSV-25 Millennium System].[经结膜玻璃体切除术:使用TSV-25 Millennium系统的初步数据]
Arq Bras Oftalmol. 2005 Nov-Dec;68(6):721-6. doi: 10.1590/s0004-27492005000600004.

引用本文的文献

1
Vitrectomy for diabetic retinopathy: A review of indications, techniques, outcomes, and complications.糖尿病性视网膜病变的玻璃体切除术:适应证、技术、疗效及并发症综述
Taiwan J Ophthalmol. 2024 Jan 31;14(4):519-530. doi: 10.4103/tjo.TJO-D-23-00108. eCollection 2024 Oct-Dec.
2
Differential distribution of fibrovascular proliferative membranes in 25-gauge vitrectomy for proliferative diabetic retinopathy.25G玻璃体切割术治疗增殖性糖尿病视网膜病变时纤维血管增殖膜的差异分布
Int J Ophthalmol. 2024 Aug 18;17(8):1462-1468. doi: 10.18240/ijo.2024.08.11. eCollection 2024.
3
Evaluation of Retinal Detachment After Diabetic Vitrectomy: Causes and Ways of Management.糖尿病玻璃体切除术后视网膜脱离的评估:病因及处理方法
Clin Ophthalmol. 2020 Jan 9;14:53-60. doi: 10.2147/OPTH.S235757. eCollection 2020.

本文引用的文献

1
Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.增殖性糖尿病视网膜病变所致玻璃体积血的当前治疗方法。
Int Ophthalmol Clin. 2014 Spring;54(2):141-53. doi: 10.1097/IIO.0000000000000027.
2
Surgical management of diabetic retinopathy.糖尿病视网膜病变的外科治疗
Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):283-92. doi: 10.4103/0974-9233.120003.
3
Evolving strategies in the management of diabetic retinopathy.糖尿病视网膜病变管理中的不断演变的策略
Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):273-82. doi: 10.4103/0974-9233.119993.
4
Clinical and histological features of epiretinal membrane after diabetic vitrectomy.糖尿病玻璃体切除术后视网膜前膜的临床和组织学特征。
Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):401-10. doi: 10.1007/s00417-013-2479-0. Epub 2013 Oct 15.
5
Rate of sclerotomy suturing in 23-gauge primary vitrectomy.23G 微创玻璃体切除术中巩膜穿刺缝线的比率。
Retina. 2014 Apr;34(4):679-83. doi: 10.1097/IAE.0b013e3182a48972.
6
Surgical results of combined pars plana vitrectomy and phacoemulsification for vitreous hemorrhage in PDR.糖尿病视网膜病变玻璃体出血行玻璃体切割联合白内障超声乳化手术的结果
Clin Ophthalmol. 2013;7:1597-601. doi: 10.2147/OPTH.S47780. Epub 2013 Aug 8.
7
[Use of bevacizumab in the treatment of complicated proliferative diabetic retinopathy].贝伐单抗在治疗复杂性增殖性糖尿病视网膜病变中的应用
J Fr Ophtalmol. 2013 Nov;36(9):758-63. doi: 10.1016/j.jfo.2012.11.015. Epub 2013 Jul 3.
8
Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中的玻璃体切除术后糖尿病性玻璃体出血
J Res Med Sci. 2012 Sep;17(9):865-71.
9
Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials.玻璃体切割术联合或不联合术前玻璃体内贝伐单抗治疗增生型糖尿病视网膜病变:一项随机对照试验的荟萃分析。
Am J Ophthalmol. 2013 Jul;156(1):106-115.e2. doi: 10.1016/j.ajo.2013.02.008.
10
Small gauge vitrectomy: Recent update.小切口玻璃体切除术:近期进展
Oman J Ophthalmol. 2013 Jan;6(1):3-11. doi: 10.4103/0974-620X.111893.